The investment seeks long-term growth of capital... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
KCE | 147.15 | 0.33 | +0.23% |
SPDR® S&P Capital Markets ETF | |||
SHYG | 43.00 | 0.08 | +0.19% |
iShares 0-5 Year High Yield Corp Bd ETF | |||
EET | 78.48 | -0.10 | -0.12% |
ProShares Ultra MSCI Emerging Markets | |||
RSPM | 32.14 | -0.04 | -0.13% |
Invesco S&P 500® Equal Weight Matrls ETF | |||
THNR | 23.36 | -0.37 | -1.56% |
Amplify Weight Loss Drug & Treatment ETF |
A.I.dvisor indicates that over the last year, JCVVX has been closely correlated with RMFEX. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if JCVVX jumps, then RMFEX could also see price increases.
Ticker / NAME | Correlation To JCVVX | 1D Price Change % | ||
---|---|---|---|---|
JCVVX | 100% | +0.84% | ||
RMFEX - JCVVX | 72% Closely correlated | +0.26% | ||
RMEBX - JCVVX | 72% Closely correlated | +0.26% | ||
RMFCX - JCVVX | 72% Closely correlated | +0.28% | ||
FFFMX - JCVVX | 60% Loosely correlated | +0.27% | ||
FFMMX - JCVVX | 59% Loosely correlated | +0.27% | ||
More |